Condition
Malignant Pleural Mesothelioma|Mesothelioma
Estimated Enrollment: 36
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: MCC-18094
Study First Received: November 18, 2015
Last Updated: February 21, 2017
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
Objective Response Rate (ORR)|Overall Survival (OS)|Progression Free Survival (PFS)|Occurrence of Treatment Related Toxicity|Quality of Life Questionnaire Scores
Sponsors and Collaborators:
H. Lee Moffitt Cancer Center and Research Institute
Website Link: https://ClinicalTrials.gov/show/NCT02611037
